INTERCEPT PHARMACEUTICALS, INC. short interest in 2022
In 2022, INTERCEPT PHARMACEUTICALS, INC.'s disclosed short interest ran from 28.36% of shares outstanding on 14 Jan 2022 to 8.74% on 30 Dec 2022, a change of -19.62 percentage points. The year's high was 38.79% on 15 Aug 2022 and its low 8.52% on 15 Dec 2022, averaging 23.30% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.55 days on 29 Jul 2022. Full history: INTERCEPT PHARMACEUTICALS, INC..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023
2022 in figures
- Start of year
- 28.36% (14 Jan 2022)
- End of year
- 8.74% (30 Dec 2022)
- Change
- -19.62 pp
- High
- 38.79% (15 Aug 2022)
- Low
- 8.52% (15 Dec 2022)
- Average
- 23.30%
- Highest days to cover
- 15.55 (29 Jul 2022)
- SEC filings marked
- 8
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 28.36% | 11.17 | |
| 31 Jan 2022 | 28.20% | 9.46 | |
| 15 Feb 2022 | 28.27% | 11.99 | |
| 28 Feb 2022 | 28.83% | 12.23 | |
| 15 Mar 2022 | 28.63% | 9.26 | 10-K filed, results (8-K) |
| 31 Mar 2022 | 27.73% | 8.24 | |
| 14 Apr 2022 | 27.70% | 12.99 | |
| 29 Apr 2022 | 26.90% | 13.57 | |
| 13 May 2022 | 29.41% | 3.63 | 10-Q filed, results (8-K) |
| 31 May 2022 | 29.99% | 14.65 | |
| 15 Jun 2022 | 32.86% | 11.15 | |
| 30 Jun 2022 | 29.94% | 13.78 | |
| 15 Jul 2022 | 34.70% | 11.16 | |
| 29 Jul 2022 | 35.77% | 15.55 | |
| 15 Aug 2022 | 38.79% | 10.53 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 18.43% | 4.19 | |
| 15 Sep 2022 | 16.63% | 7.86 | |
| 30 Sep 2022 | 12.45% | 3.08 | |
| 14 Oct 2022 | 9.71% | 4.97 | |
| 31 Oct 2022 | 10.07% | 6.67 | |
| 15 Nov 2022 | 9.62% | 4.56 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 8.92% | 8.65 | |
| 15 Dec 2022 | 8.52% | 6.23 | |
| 30 Dec 2022 | 8.74% | 2.97 |
See also: INTERCEPT PHARMACEUTICALS, INC.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.